Provided by Tiger Fintech (Singapore) Pte. Ltd.

bluebird bio

4.95
+0.06001.23%
Post-market: 4.950.00000.00%19:48 EDT
Volume:218.89K
Turnover:1.06M
Market Cap:48.46M
PE:-0.20
High:4.99
Open:4.92
Low:4.67
Close:4.89
Loading ...

Biotech Stock Roundup: CORT Up on Study Data, Updates From AXSM, BMY, EXEL & More

Zacks
·
03 Apr

BRIEF-Xcellbio Granted Bluebird Bio Commercial License, Got Into Supply Agreement For Use Of Co's Proprietary Cell Manufacturing Technology, Avatar

Reuters
·
02 Apr

Xcellbio: Granted bluebird bio Commercial License, Got Into Supply Agreement for Use of Co's Proprietary Cell Manufacturing Technology, Avatar

THOMSON REUTERS
·
02 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Veritex, Gaming and Leisure Properties, Apple

Reuters
·
01 Apr

bluebird bio Is Maintained at Overweight by Barclays

Dow Jones
·
31 Mar

Bluebird Bio Shares Rise After Non-Binding Offer From Ayrmid

Dow Jones
·
31 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Gene therapy cos, gold miners, chipmakers

Reuters
·
31 Mar

BUZZ-Bluebird bio rises on non-binding bid for up to $110.5 million

Reuters
·
31 Mar

Bluebird bio receives non-binding bid for up to $110.5 million

Reuters
·
29 Mar

BUZZ-Bluebird Bio shares rally 11% in late trade on buyout offer

Reuters
·
29 Mar

Bluebird Bio Reviewing Competing Buyout Offer From Ayrmid for Up to $110.5 Million

Dow Jones
·
29 Mar

Bluebird Bio Gets Rival Buyout Proposal From Ayrmid; Shares Jump After Hours

MT Newswires Live
·
29 Mar

BRIEF-Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From Ayrmid

Reuters
·
29 Mar

bluebird bio Inc Shares Gain Ground After the Bell Following Confirmation It Received Unsolicited Proposal, Last up 13% at Around $4.60

THOMSON REUTERS
·
29 Mar

Bluebird Bio confirms receipt non-binding proposal from Ayrmid

TIPRANKS
·
29 Mar

bluebird bio Inc - Board Reviewing Ayrmid Proposal With Advisors

THOMSON REUTERS
·
29 Mar

bluebird bio Inc - Ayrmid Did Not Submit Any Proposal to Bluebird as Part of Its Review of Strategic Alternatives

THOMSON REUTERS
·
29 Mar

bluebird bio Inc - Not Changed Its Recommendation in Support of Carlyle and SK Capital Partners Deal

THOMSON REUTERS
·
29 Mar

bluebird bio Confirms Receipt of an Unsolicited Non-Binding Proposal From Ayrmid

THOMSON REUTERS
·
29 Mar

Press Release: bluebird bio Confirms Receipt of an Unsolicited Non-Binding Proposal from Ayrmid

Dow Jones
·
29 Mar